AMN Healthcare Services, Inc.
AMN Healthcare Services, Inc. Q3 FY2025 earnings call
November 6, 2025 · fiscal period ended 2025-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-11-06
Management highlights
Management Statement and Operational Highlights
- AMN has continued to adapt to market changes. Third quarter revenue of $634 million was $9 million above guidance range. Consolidated gross margin was near upper end of guidance, adjusted EBITDA 9.1% of revenue. Staffing demand recovered, extension rates rebounded, and Travel Nurse winter orders were slightly favorable. Gross margin declined due to unfavorable revenue mix and competitive pressures, but plan to improve margins in 2026 with international staffing and high-margin services. Strong client retention and Net Promoter Scores. Progress in technology, processes, and customer focus.
- Nurse and Allied: Beat consensus revenue, Labor Disruption revenue contributed. Q4 revenue guidance is $715 million to $730 million, including approximately $100 million related to Labor Disruption support.
- Physician and Leadership: Locum Tenens revenue up, Interim Leadership down, Search revenue flat. Q4 revenue projected to be down sequentially by approximately 6% due to seasonally lower Locum's volume.
- Technology and Workforce: Impact from Smart Square sale, VMS and Language Services declines. Q4 expected mid-single-digit decline in revenue.
Segment performance
Segment Performance
- Nurse and Allied Solutions: Third quarter revenue was $361 million, down 9% from the prior year but exceeding the high end of guidance, driven by higher-than-expected Travel Nurse volume and $12 million of Labor Disruption revenue. Sequentially, segment revenue was down 5%. Year-over-year, volume decreased 11% with average rate and hours work flat. Sequentially, volume was down 6% with average rate down 1% and hours work flat. Q4 expected ~$100 million in Labor Disruption revenue. Total Nurse and Allied revenue will be up low single digits year-over-year or down approximately 6% to 8% ex-Labor Disruption, best year-over-year comparison in 3 years. Gross margin in Q3 was 24.1%, expected to be approximately 21% in Q4.
- Physician and Leadership Solutions: Third quarter revenue was $178 million, down 1% year-over-year but up 2% sequentially, mainly driven by Locum Tenens' performance. Locum Tenens' revenue was up 3% year-over-year and 2% sequentially. Interim leadership revenue decreased 20% year-over-year but was up 2% sequentially. Search revenue was down 7% year-over-year and flat sequentially. Gross margin was 27.2%, down 110 basis points year-over-year, expected to remain consistent with Q3 in Q4.
- Technology and Workforce Solutions: Third quarter revenue was $95 million, down 12% year-over-year and 7% sequentially, primarily due to the sale of Smart Square, lower VMS revenue, and Language Services revenue decline. Q4 expected mid-single-digit decline compared to Q3 due to seasonally lower language services minutes and client transitions. Gross margin was 51.5%, down 640 basis points year-over-year, expected to step down by about 100 basis points in Q4.
Guidance
Guidance
- Consolidated revenue for Q4 projected to be in the range of $715 million to $730 million, including approximately $100 million related to Labor Disruption support.
- Gross margin projected to be between 25.5% and 26%. Excluding Labor Disruption revenue, gross margin would be higher by about 100 basis points.
- Reported SG&A expenses projected to be approximately 20% to 20.5% of revenue, including about $5 million of additional costs in the quarter to support Labor Disruption activity.
- Operating margin expected to be 0.2% to 0.8% and adjusted EBITDA margin expected to be 6.8% to 7.3%.
Risks
Risks
- Competitive pressures in Staffing and Language services.
- Unfavorable revenue mix shift impacting gross margins.
- Impact of labor cost increases and inflation on bill rates, potentially affecting margins.
- Potential impact of federal health care funding cuts on client demand for contingent labor.
Q&A highlights
Question and Answer
- Q: About margin guidance, drivers of gross margin compression.
A: Brian Scott mentioned revenue mix, seasonality, and timing of Labor Disruption support as drivers, with a benefit in Q3 margin and drag in Q4 due to lower margin profile of Labor Disruption-related revenue.
- Q: EBITDA margin outlook ex-Labor Disruption.
A: Brian Scott stated it would be in the mid-6s range.
- Q: Sequential volume growth in Q4.
A: Caroline Grace said demand improved broader than just winter orders, with growth from May low point and healthy winter orders contributing.
- Q: Impact of federal health care funding cuts on contingent labor demand.
A: Caroline Grace said clients are focused on revenue growth and cost containment, seeing contingent labor as affordable and flexible.
- Q: Clinician supply and bill rate expectations.
A: Caroline Grace and Brian Scott discussed healthy supply in some areas, need for competitive bill rates to fill orders, and investments in clinician experience and technology to attract supply.
- Q: New business opportunities and MSP trends.
A: Caroline Grace mentioned pipeline growth, bias towards MSP in pipeline, momentum in extensions, and focus on total talent solutions to combat competition.
- Q: Strike margin impact and Labor Disruption trends.
A: Brian Scott explained margin benefit in Q3 from Labor Disruption services and guidance adjustments for Q4 margin drag due to lower margin profile of Labor Disruption-related revenue in Nurse and Allied.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.39 | $0.19 | +104.2% | — |
| Revenue | $634.5M | $716.4M | -11.4% | — |
Transcript
November 6, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.